Zhang R, Jiang Y, Gu J, Zhang X, Xie Y
BMC Cancer. 2025; 25(1):47.
PMID: 39789501
PMC: 11721336.
DOI: 10.1186/s12885-024-13393-1.
Li F, Li W
Biomolecules. 2024; 14(7).
PMID: 39062595
PMC: 11275166.
DOI: 10.3390/biom14070881.
Liu L, Gong P, Li X, Zhang L, Niu J, Zhu J
Acta Biochim Biophys Sin (Shanghai). 2024; 57(2):182-194.
PMID: 38899362
PMC: 11868936.
DOI: 10.3724/abbs.2024093.
Wu L, Huang S, Tian W, Liu P, Xie Y, Qiu Y
Cell Death Discov. 2024; 10(1):7.
PMID: 38182573
PMC: 10770055.
DOI: 10.1038/s41420-023-01771-w.
Fu J, Yu L, Yan H, Tang S, Wang Z, Dai T
Front Mol Biosci. 2023; 10:1297198.
PMID: 38152110
PMC: 10751344.
DOI: 10.3389/fmolb.2023.1297198.
Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma.
Jiang W, Xu Z, Huang L, Qin F, Yuan L, Sun Y
BMC Med Genomics. 2023; 16(1):330.
PMID: 38110999
PMC: 10726503.
DOI: 10.1186/s12920-023-01764-9.
Identifying phenotype-associated subpopulations through LP_SGL.
Li J, Zhang H, Mu B, Zuo H, Zhou K
Brief Bioinform. 2023; 25(1).
PMID: 38008419
PMC: 10753413.
DOI: 10.1093/bib/bbad424.
Long noncoding RNA study: Genome-wide approaches.
Tao S, Hou Y, Diao L, Hu Y, Xu W, Xie S
Genes Dis. 2023; 10(6):2491-2510.
PMID: 37554208
PMC: 10404890.
DOI: 10.1016/j.gendis.2022.10.024.
The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
Liu T, Sun L, Li Z, Yang K, Chen J, Han X
BMC Gastroenterol. 2023; 23(1):147.
PMID: 37170222
PMC: 10173529.
DOI: 10.1186/s12876-023-02776-6.
SNORD17-mediated KAT6B mRNA 2'-O-methylation regulates vasculogenic mimicry in glioblastoma cells.
Cui J, Liu X, Dong W, Liu Y, Ruan X, Zhang M
Cell Biol Toxicol. 2023; 39(6):2841-2860.
PMID: 37058271
DOI: 10.1007/s10565-023-09805-w.
PCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression.
Liu Y, Xie C, Li T, Lu C, Fan L, Zhang Z
BMC Womens Health. 2023; 23(1):104.
PMID: 36915057
PMC: 10012497.
DOI: 10.1186/s12905-023-02250-1.
Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma.
Lu J, Yan Z, Xu T, Zhao F, Liu L, Li F
Cell Death Dis. 2023; 14(1):72.
PMID: 36717549
PMC: 9886991.
DOI: 10.1038/s41419-023-05605-6.
Pan-cancer analysis of LINC02535 as a potential biomarker and its oncogenic role in lung adenocarcinoma.
Dai S, Liu T, He Y, Huang Y, Wang L, Luo F
Heliyon. 2022; 8(12):e12108.
PMID: 36544816
PMC: 9761721.
DOI: 10.1016/j.heliyon.2022.e12108.
Construction of a multiple-class classifier based on mRNAs and lncRNA FAM66A and PSORS1C3 for predicting distant metastasis in lung adenocarcinoma.
Lin G, Gao Z, Zheng X, Zheng J, Ye S, Wang Z
Ann Transl Med. 2022; 10(20):1129.
PMID: 36388820
PMC: 9652512.
DOI: 10.21037/atm-22-4651.
Necroptosis-related lncRNA in lung adenocarcinoma: A comprehensive analysis based on a prognosis model and a competing endogenous RNA network.
Mao F, Li Z, Li Y, Huang H, Shi Z, Li X
Front Genet. 2022; 13:940167.
PMID: 36159965
PMC: 9493131.
DOI: 10.3389/fgene.2022.940167.
Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma.
Tong F, Xu L, Xu S, Zhang M
Front Genet. 2022; 13:834935.
PMID: 36105077
PMC: 9466988.
DOI: 10.3389/fgene.2022.834935.
LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma.
Wang Y, Feng Y, Gan Y, Teng L, Wang L, La T
J Exp Clin Cancer Res. 2022; 41(1):260.
PMID: 36028903
PMC: 9414127.
DOI: 10.1186/s13046-022-02452-9.
LINC00665/miRNAs axis-mediated collagen type XI alpha 1 correlates with immune infiltration and malignant phenotypes in lung adenocarcinoma.
Zhu J, Weng Y, Wang F, Zhao J
Open Med (Wars). 2022; 17(1):1259-1274.
PMID: 35892083
PMC: 9281593.
DOI: 10.1515/med-2022-0478.
Risk coefficient model of necroptosis-related lncRNA in predicting the prognosis of patients with lung adenocarcinoma.
Chen H, Xie Z, Li Q, Qu G, Tan N, Zhang Y
Sci Rep. 2022; 12(1):11005.
PMID: 35768485
PMC: 9243036.
DOI: 10.1038/s41598-022-15189-4.
Comprehensive Analysis of 5-Methylcytosine (mC) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy.
Wang R, Guo Y, Ma P, Song Y, Min J, Zhao T
Front Oncol. 2022; 12:851766.
PMID: 35433474
PMC: 9009261.
DOI: 10.3389/fonc.2022.851766.